Research Topic · Peer-Reviewed

Chemotherapy-induced Peripheral Neuropathy

(CIPN) Chemotherapy-induced peripheral neuropathy (CIPN) is a set of side effects caused by chemotherapy that affect the peripheral nervous system. It is characterized by symptoms such as tingling, numbness, and burning in the hands and feet and can lead to problems with coordination, balance, and walking. CIPN can…

📚 0 peer-reviewed articles cited 🗓 Reviewed June 2026

Overview

(CIPN) Chemotherapy-induced peripheral neuropathy (CIPN) is a set of side effects caused by chemotherapy that affect the peripheral nervous system. It is characterized by symptoms such as tingling, numbness, and burning in the hands and feet and can lead to problems with coordination, balance, and walking. CIPN can be a debilitating side effect of chemotherapy and can prevent people from continuing treatment. Recent treatments, such as nerve-protecting agents and exercise, have been found to reduce the severity of CIPN and help people continue their chemotherapy sessions. Prevention and management of CIPN are essential for chemotherapy patients to improve their quality of life.

Research published in this journal

No peer-reviewed research on this exact topic has been published in International Journal of Chemotherapy Research and Practice yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in International Journal of Chemotherapy Research and Practice.

Journal editorial board
Monika Sakowicz-Burkiewicz · Poland M. Waheed Roomi · United States Silvia Lemma · Italy

This page summarises published research for orientation; it is not medical or professional advice.